Palani Santhosh bought ACRV
March 4, 2024 · Form 4 insider transaction
Palani Santhosh bought 32,500 shares of Acrivon Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
32,500
Price
$0.00
Total value
N/A
InsiderPalani Santhosh
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 4, 2024
Filing dateMarch 6, 2024
Shares owned after32,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest in 36 substantially equal monthly installments beginning on March 4, 2024 ("Vesting Commencement Date"), such that all shares are fully vested on the third anniversary of the Vesting Commencement Date, in each case subject to the Reporting Person's continuous service through each such vesting date.